Browsing by Author Fereday, Sian

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)Citation
2008ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapydeFazio, Anna; Harnett, Paul; AOCS, Study Group; Beesley, Johnathan; Brown, Robert; Byth, Karen; Chenevix-Trench, Georgia; Fereday, Sian; Johnatty, Sharon E.; Marsh, Sharon; McLeod, Howard; Paul, Jim; Spurdle, Amanda B.; Webb, Penelope M.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy, Clinical Cancer Research, vol.14, 17, 2008,pp 5594-5601
2013ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome AtlasdeFazio, Anna; Emmanuel, Catherine; Gao, Bo-Fu; Beesley, Johnathan; Chen, Xiaoqing; et al, Various; Fereday, Sian; Hedditch, Ellen; Henderson, Michelle; Johnatty, Sharon E.; Law, Matthew; Lu, Yi; Russell, Amanda; Webb, Penelope M.; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas, Gynecologic Oncology, vol.131, 1, 2013,pp 8-14
2006Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resourceBalleine, Rosemary; Butow, Phyllis; Clarke, Christine; Kirk, Judy; Leary, Jennifer; Mann, Graham; Pupo, Gulietta; Chenevix-Trench, Georgia; Edkins, Edward; Evans, Gerda M.; Fereday, Sian; Gattas, Michael; Giles, Graham; Goldblatt, Jack; Haan, Eric; Hopper, John; Lindeman, Geoffrey J; Niedermayr, Eveline; Phillips, Kelly-Anne; Picken, Sandra; Saunders, Christobel; Scott, Clare L; Spurdle, Amanda B.; Suthers, Graeme; The Kathleen Cuningham Consortium for Research in Familial Breast Cancer, kConFab; Thorne, Heather; Tucker, Katherine M.; Western Clinical School: Medicine (Westmead); Psychology; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource, Breast Cancer Research, vol.8,(1),2006,pp N/A-N/A
2012BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupdeFazio, Anna; Emmanuel, Catherine; Alsop, Kathryn; Birrer, Michael; Bowtell, David D L; Dobrovic, Alexander; Fereday, Sian; Fox, Stephen B.; Friedlander, Michael; George, Joshy; Meldrum, Cliff; Mitchell, Gillian; Stewart, Colin; Webb, Penelope M.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteBRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group, Journal of Clinical Oncology, vol.30, 21, 2012,pp 2654-2663
2010Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.deFazio, Anna; Sharma, Raghwa; Ahmed Ashoure, Ahmed; Bowtell, David D L; Brenton, James D; Caldas, Carlos; Etemadmoghadam, Dariush; Fereday, Sian; Lynch, Andy; Riad, Mohamed; Stewart, Colin L.; Temple, Jillian; Western Clinical School: Westmead Millennium Institute; MedicineDriver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary., Journal of Pathology, vol.221, 1,pp 49-56
2017EIF1AX and NRAS mutations co-occur and cooperate in low-grade serous ovarian carcinomasdeFazio, Anna; Harnett, Paul; Lei, Ying; Moujaber, T; Sharma, Raghwa; Azar, Walid; Chiew, Yoke-Eng; et al, Various; Etemadmoghadam, Dariush; Fereday, Sian; Garsed, Dale; Hendley, Joy; Kennedy, Catherine; Li, Jason; Mitchell, Chris; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Medicine; Medicine; Medicine; Westmead Clinical School: PathologyEIF1AX and NRAS mutations co-occur and cooperate in low-grade serous ovarian carcinomas, Cancer Research, vol.77, 16, 2017,pp 4268-4278
2014Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driverBalleine, Rosemary; Brand, Alison; Clarke, Christine; deFazio, Anna; Emmanuel, Catherine; Harnett, Paul; Hogg, Russell; Kennedy, Catherine Jane; Sharma, Raghwa; Wain, Gerard; Anglesio, Michael S.; Chiew, Yoke-Eng; et al, Various; Etemadmoghadam, Dariush; Fereday, Sian; Galletta, Laura; George, Joshy; Hung, Jillian A.; MacConaill, Laura; Palescandolo, Emanuele; Russell, P; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Pathology; Western Clinical School: Obstetrics & GynaecologyGenomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver, Clinical Cancer Research, vol.20, 24, 2014,pp 6618-6630
2013High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better SurvivaldeFazio, Anna; Alsop, Kathryn; Børresen-Dale, Anne Lise; Baumbusch, Lars; Bowtell, David D L; Brown, Pat; Etemadmoghadam, Dariush; Fereday, Sian; Helland, Aslaug; Holm, Ruth; Kristensen, Gunnar; Liestöl, Knut; Lingjærde, Ole Christian; Mitchell, Gillian; Schaner, Marci; Wang, Yun; Western Clinical School: Westmead Millennium InstituteHigh Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival, PLoS One, vol.8, 1, 2013,pp 1-8
2012LRP1B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemotherapy Resistance to Liposomal DoxorubicindeFazio, Anna; Harnett, Paul; Anglesio, Michael; Cowin, Prue; Cullinane, Carleen; et al, Various; Etemadmoghadam, Dariush; Fereday, Sian; Ftouni, Sarah; Galletta, Laura; George, Joshy; Loehrer, Elizabeth; Van Loo, Peter; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)LRP1B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemotherapy Resistance to Liposomal Doxorubicin, Cancer Research, vol.72, 16, 2012,pp 4060-4073
2008Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.deFazio, Anna; Russell, Peter; Anglesio, Michael S.; Arnold, Jeremy; Australian Ovarian Cancer Study Group, (AOCSG); Birrer, Michael J.; Bowtell, David D L; Chenevix-Trench, Georgia; Fereday, Sian; George, Joshy; Locandro, Bianca; Sharma, Raghwa; Simms, Lisa; Tinker, A. V.; Tothill, Richard W.; Traficante, Nadia; Waddell, Nic; Western Clinical School: Westmead Millennium Institute; Central Clinical School: PathologyMutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors., Molecular Cancer Research, vol.6, 11, 2008,pp 1678-1690
2008Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.deFazio, Anna; Australian Ovarian Cancer Study Group, (AOCSG); Bowtell, David D L; Brown, Robert; Chiew, Yoke-Eng; Etemadmoghadam, Dariush; Fereday, Sian; Fox, Stephen B.; George, Joshy; Gertig, Dorota; Haviv, Izhak; Hung, Jillian A.; Johnson,, Daryl S.; Lade, Stephen; Locandro, Bianca; Tinker, Anna V.; Tothill, Richard W.; Traficante, Nadia; Trivett, Melanie K.; Western Clinical School: Westmead Millennium InstituteNovel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome., Clinical Cancer Research, vol.14, 16, 2008,pp 5198-5208
2011Reducing Time to Diagnosis Does Not Improve Outcomes for Women With Symptomatic Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupdeFazio, Anna; Bowtell, David D L; Fereday, Sian; Francis, Jane E.; Green, Adele C.; Luxford, Karen; Nagle, Christina M.; Nelson, Anne E.; Webb, Penelope M.; Zorbas, Helen; Western Clinical School: Westmead Millennium InstituteReducing Time to Diagnosis Does Not Improve Outcomes for Women With Symptomatic Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group, Journal of Clinical Oncology, vol.29, 16, 2011,pp 2253-2258
2016The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancerClarkson, Adele; Clifton-Bligh, Roderick; Cole, Alexander J; deFazio, Anna; Dickson, Kristie-Ann; Gill, Anthony; Henderson, Beric; Kennedy, Catherine Jane; Marsh, Deborah; Alsop, Kathryn; Bowtell, David D L; Chou, Angela; Fereday, Sian; Gard, Gregory; Traficante, Nadia; Northern Clinical School: Pathology; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Western Clinical School: Westmead Institute for Medical Res; Northern Clinical School: Medicine; Northern Clinical School: Pathology; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Obstetrics & Gynaecology; Northern Clinical School: Kolling InstituteThe RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer, Human Molecular Genetics, vol.25, 24, 2016,pp 5460-5471
2015Whole-genome characterization of chemoresistant ovarian cancerChiew, Yoke-Eng; deFazio, Anna; Harnett, Paul; Hung, Jillian; Kennedy, Catherine Jane; McNally, Orla; Alsop, Kathryn; Bailey, Peter; Christie, Elizabeth; Cowin, Prue; et al, Various; Etemadmoghadam, Dariush; Fereday, Sian; Garsed, Dale; George, Joshy; Nones, Katia; Patch, Anne-Marie; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteWhole-genome characterization of chemoresistant ovarian cancer, Nature, vol.521, 7553, 2015,pp 489-494